Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Orexo Falls as Much as 20% After J&J Drug Research Deal Canceled

Orexo AB fell as much as 20 percent, the most since November 2005, in Stockholm trading after saying drug research and licensing deals with Johnson & Johnson subsidiaries had been terminated. The shares traded down 4.1 kronor, or 15 percent, to 23.80 kronor at 9:15 a.m.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.